BioSpace News Archive

BIONIK Laboratories Corp. (OTCQB:BNKL) (“BIONIK”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it has received regulatory approval in South Korea, and that its exclusive distributor Curexo secured the first sale for BIONIK’s InMotion® robotic technology in the country, out of Curexo’s existing inventory.

Hitachi Chemical Advanced Therapeutics Solutions, LLC (“HCATS”), a subsidiary of Hitachi Chemical Co., Ltd. representing Hitachi Chemical’s Regenerative Medicine Business Sector (“RMBS”) in North America, today announced the opening of its new cell and gene therapy manufacturing facility in Allendale, New Jersey.

Diverse Biotech, Inc. www.diversebiotech.com has announced it has been selected to present at the following prestigious events.

Next Generation Technology Includes Features that Automatically Adjust to Patient Needs, and Offers Physicians Heart Failure Diagnostic Insights DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE ( Conformité Européenne ) Mark for its Cobalt™ and Crome™ portfolio of implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D).

InCrowd, life science industry leader for real-time, high-quality primary market intelligence, ended 2019 with a record fourth-quarter performance and continued strong growth, capping an extraordinary year as measured by revenue, customers, and market impact.

ANAHEIM, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, has been awarded an additional $2.8 million. This is the second tranche from the total grant of approximately $5.7 million announced last year. The grant was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under award number UG3DA047925

Medin Technologies, Inc., the leading independent U.S. manufacturer of sterilization cases and trays for the orthopedic implant and instrument industry, announced today the appointment of Jim Engler as Chief Financial Officer and Gregg Olson as Vice President of Sales and Marketing

Astellas Pharma Inc. and FibroGen, Inc. announced the submission of a supplemental New Drug Application to Japan’s Ministry of Health, Labour and Welfare to gain marketing approval for Evrenzo® for the treatment of anemia associated with chronic kidney disease in non-dialysis dependent patients.

Transaction adds comprehensive gene editing capabilities and engine to drive expansion of Abcam’s ‘off-the-shelf’ edited cell line portfolio

Arranta Bio announced the strengthening of its senior leadership team with the addition of David Stevens as Chief Operations Officer and Jason Rahal as Senior Vice President of Business Development.